Search

everythinglearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

A male with aromatase deficiency improved bone health with estradiol treatment.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

DHT may increase the risk of heart disease and death in elderly men.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.